Indications for anti-VEGF injection were as follows: 17 patients with RVOs, 39 with nAMD, 20 with DME, and 3 with other causes (i.e., histoplasmosis, central serous chorioretinopathy). This evidence concerns the gene VEGFA and central serous retinopathy.